Insulin Shoot Out: People Over Profit

The Insulin Shoot Out continues this week as we sit down with Ron James, President of Ivolve Media Group, who gets to ask CEO of MannkindMike Castagna about the diabetes industry, insulin profit margins, and the ins and out of the healthcare system. To Ron’s surprise, he learns from Mike that Afrezza - the only inhaled insulin - is CHEAPER THAN INJECTABLE INSULIN.